Carbinoxamine
Aminoalkyl Ethers
- Drug class
- Aminoalkyl Ethers
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 4
Overview
Plain-language summary, compiled from the cited regulatory records
Carbinoxamine is an antihistamine belonging to the aminoalkyl ethers drug class [1]. It is approved for the symptomatic treatment of various allergic conditions. These include seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis [1]. Carbinoxamine is also indicated for allergic conjunctivitis caused by airborne allergens and certain foods [1].
Furthermore, carbinoxamine is used to treat mild, uncomplicated allergic skin reactions such as urticaria and angioedema [1]. It can also be used for dermatographism and as adjunctive therapy alongside epinephrine and other standard treatments for anaphylactic reactions, once the acute symptoms have been managed [1]. It may also be used to lessen the severity of allergic reactions [1].
This active ingredient is available under several brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | March 12, 2026 |
USUnited States· FDA
4 products
Uses
INDICATIONS AND USAGE
Carbinoxamine maleate is effective for the symptomatic treatment of:
Seasonal and perennial allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
Amelioration of the severity of allergic reactions to blood or plasma.
How to take
Drug interactions
Known interactions involving Carbinoxamine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 272. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 02e13b55-2153-46… · revised July 18, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.